2005
DOI: 10.1016/j.jtcvs.2005.08.049
|View full text |Cite
|
Sign up to set email alerts
|

Experimental study on the protective effects of edaravone against ischemic spinal cord injury

Abstract: Edaravone exerted a significant protective effect on the spinal cord against ischemia-reperfusion injury by suppressing the level of free radical species, which was demonstrated with the microdialysis method.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 26 publications
1
31
0
Order By: Relevance
“…In addition, Eda not only had antioxidant roles, but also protected cells from apoptosis [16,17] . However, little information is available on antioxidant Eda in regulating the Bcl-2/Bax apoptotic pathway via mitochondria after CoCl 2 injury at cellular level.…”
Section: Discussionmentioning
confidence: 97%
“…In addition, Eda not only had antioxidant roles, but also protected cells from apoptosis [16,17] . However, little information is available on antioxidant Eda in regulating the Bcl-2/Bax apoptotic pathway via mitochondria after CoCl 2 injury at cellular level.…”
Section: Discussionmentioning
confidence: 97%
“…A previous study showed that edaravone could decrease calcium overloading, increase mitochondrial potential, and reduce neuronal apoptosis through inhibiting lipid peroxidation in the rat hippocampal I/R model [15] . Wen et al reported that edaravone could relieve oxidative stress through inhibiting the JNK-c-Jun pathway in the senile rat cerebral I/R model and therefore protect cerebral neurons [14] . The present study has indicated the involvement of antioxidative and antiapoptotic effects of edaravone on photoreceptor cells in the rat retinal I/R model, but whether these 2 pathways also apply to the retinal I/R injury model warrants further study.…”
Section: Discussionmentioning
confidence: 99%
“…Using a rat model of transient middle cerebral artery occlusion (MCAO), the data showed that daily treatment with edaravone reduced cortical infarction volume. In addition, edaravone not only has antioxident action, but also protects cells from apoptosis (Kokura et al, 2005;Suzuki et al, 2005). However, little information is available on antioxidant edaravone in regulating the Bcl-2/Bax apoptotic pathway via mitochondria after OGD-reperfusion injury at cellular level.…”
Section: Introductionmentioning
confidence: 99%